{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:17:17Z","timestamp":1790691437593,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-024-01677-4","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:13:22Z","timestamp":1734743602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Meng-Hua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Xia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"3","key":"1677_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10364","key":"1677_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400(10364):1712\u201321.","journal-title":"Lancet"},{"issue":"16","key":"1677_CR3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"issue":"1","key":"1677_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-022-04706-x","volume":"23","author":"EB Fauman","year":"2022","unstructured":"Fauman EB, Hyde C. An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLs. BMC Bioinformatics. 2022;23(1):169.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1677_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, Manipur I, Slob EAW, Patel A, Wallace C, Burgess S. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am J Hum Genet. 2022;109(5):767\u201382.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1677_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12916-024-03607-5","volume":"22","author":"S Burgess","year":"2024","unstructured":"Burgess S, Woolf B, Mason AM, Ala-Korpela M, Gill D. Addressing the credibility crisis in Mendelian randomization. BMC Med. 2024;22(1):374.","journal-title":"BMC Med"},{"issue":"4","key":"1677_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.tig.2021.12.002","volume":"38","author":"S Liu","year":"2022","unstructured":"Liu S, Crawford DC. Maturation and application of phenome-wide association studies. Trends Genet. 2022;38(4):353\u201363.","journal-title":"Trends Genet"},{"issue":"7708","key":"1677_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73\u20139.","journal-title":"Nature"},{"issue":"6569","key":"1677_CR9","doi-asserted-by":"publisher","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W\u00f6rheide MA, Oerton E, Cook J, Stewart ID, Kerrison ND, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374(6569):eabj1541.","journal-title":"Science"},{"key":"1677_CR10","doi-asserted-by":"crossref","unstructured":"Walker VM, Zheng J, Gaunt TR, Smith GD. Phenotypic Causal Inference Using Genome-Wide Association Study Data: Mendelian Randomization and Beyond. Annu Rev Biomed Data Sci. 2022;5:1\u201317.","DOI":"10.1146\/annurev-biodatasci-122120-024910"},{"issue":"3","key":"1677_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1677_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543\u201352.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"1677_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"8","key":"1677_CR14","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. 2014;67(8):850\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1677_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13059-019-1716-1","volume":"20","author":"K Korthauer","year":"2019","unstructured":"Korthauer K, Kimes PK, Duvallet C, Reyes A, Subramanian A, Teng M, Shukla C, Alm EJ, Hicks SC. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20(1):118.","journal-title":"Genome Biol"},{"issue":"1","key":"1677_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13040-021-00267-6","volume":"14","author":"TG Drivas","year":"2021","unstructured":"Drivas TG, Lucas A, Ritchie MD. eQTpLot: a user-friendly R package for the visualization of colocalization between eQTL and GWAS signals. BioData Min. 2021;14(1):32.","journal-title":"BioData Min"},{"issue":"7","key":"1677_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100927","volume":"17","author":"X Huang","year":"2024","unstructured":"Huang X, Shen R, Zheng Z. Unraveling genetic threads: Identifying novel therapeutic targets for allergic rhinitis through Mendelian randomization. World Allergy Organ J. 2024;17(7): 100927.","journal-title":"World Allergy Organ J"},{"issue":"11","key":"1677_CR18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"W-M Su","year":"2023","unstructured":"Su W-M, Gu X-J, Dou M, Duan Q-Q, Jiang Z, Yin K-F, Cai W-C, Cao B, Wang Y, Chen Y-P. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2023;94(11):954\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1677_CR19","doi-asserted-by":"publisher","first-page":"1366736","DOI":"10.3389\/fimmu.2024.1366736","volume":"15","author":"W Zhao","year":"2024","unstructured":"Zhao W, Fang P, Lai C, Xu X, Wang Y, Liu H, Jiang H, Liu X, Liu J. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis. Front Immunol. 2024;15:1366736.","journal-title":"Front Immunol"},{"issue":"5","key":"1677_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"M-JA Brion","year":"2013","unstructured":"Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"1677_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40264-020-00915-6","volume":"43","author":"RN Jerome","year":"2020","unstructured":"Jerome RN, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, Pulley JM. Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Drug Saf. 2020;43(6):567\u201382.","journal-title":"Drug Saf"},{"issue":"3","key":"1677_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrg.2015.36","volume":"17","author":"WS Bush","year":"2016","unstructured":"Bush WS, Oetjens MT, Crawford DC. Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat Rev Genet. 2016;17(3):129\u201345.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1677_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ejhg.2014.123","volume":"23","author":"Z Ye","year":"2015","unstructured":"Ye Z, Mayer J, Ivacic L, Zhou Z, He M, Schrodi SJ, Page D, Brilliant MH, Hebbring SJ. Phenome-wide association studies (PheWASs) for functional variants. Eur J Hum Genet. 2015;23(4):523\u20139.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1677_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2017;71(1):96\u2013108.","journal-title":"Eur Urol"},{"key":"1677_CR25","doi-asserted-by":"crossref","unstructured":"Senevirathne A, Aganja RP, Hewawaduge C, Lee JH. Inflammation-Related Immune-Modulatory SLURP1 Prevents the Proliferation of Human Colon Cancer Cells, and Its Delivery by Salmonella Demonstrates Cross-Species Efficacy against Murine Colon Cancer. Pharmaceutics. 2023;15(10):2462.","DOI":"10.3390\/pharmaceutics15102462"},{"issue":"4","key":"1677_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112377","volume":"42","author":"I Steiner","year":"2023","unstructured":"Steiner I, Flores-Tellez T, Mevel R, Ali A, Wang P, Schofield P, Behan C, Forsythe N, Ashton G, Taylor C, et al. Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Rep. 2023;42(4): 112377.","journal-title":"Cell Rep"},{"key":"1677_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40364-020-00232-1","volume":"8","author":"N Andersson","year":"2020","unstructured":"Andersson N, Ohlsson J, Wahlin S, Nodin B, Boman K, Lundgren S, Jirstr\u00f6m K. Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer. Biomark Res. 2020;8:51.","journal-title":"Biomark Res"},{"issue":"4","key":"1677_CR28","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1073\/pnas.95.4.1735","volume":"95","author":"RE Reiter","year":"1998","unstructured":"Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A. 1998;95(4):1735\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1677_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12935-024-03320-6","volume":"24","author":"T Nayerpour Dizaj","year":"2024","unstructured":"Nayerpour Dizaj T, Doustmihan A, Sadeghzadeh Oskouei B, Akbari M, Jaymand M, Mazloomi M, Jahanban-Esfahlan R. Significance of PSCA as a novel prognostic marker and therapeutic target for cancer. Cancer Cell Int. 2024;24(1):135.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1677_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1006\/bbrc.2000.3393","volume":"275","author":"G Bahrenberg","year":"2000","unstructured":"Bahrenberg G, Brauers A, Joost HG, Jakse G. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun. 2000;275(3):783\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1677_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/gtmb.2022.0067","volume":"27","author":"XF Wang","year":"2023","unstructured":"Wang XF, Liu DL, Geng L. The PSCA rs2294008 (C\/T) Polymorphism Increases the Risk of Gastric and Bladder Cancer: A Meta-Analysis. Genet Test Mol Biomarkers. 2023;27(2):44\u201355.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"2","key":"1677_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/21681805.2022.2049362","volume":"56","author":"G Gakis","year":"2022","unstructured":"Gakis G, Perner S, Stenzl A, Renninger M. The role of single-nucleotide polymorphisms of the 8q24 chromosome region in patients with concomitant bladder and prostate cancer. Scand J Urol. 2022;56(2):126\u201330.","journal-title":"Scand J Urol"},{"issue":"1","key":"1677_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13721-024-00460-7","volume":"13","author":"IA Al-Ghafer","year":"2024","unstructured":"Al-Ghafer IA, AlAfeshat N, Alshomali L, Alanee S, Qattous H, Azzeh M, Alkhateeb A. NMF-guided feature selection and genetic algorithm-driven framework for tumor mutational burden classification in bladder cancer using multi-omics data. Network Modeling Analysis in Health Informatics and Bioinformatics. 2024;13(1):26.","journal-title":"Network Modeling Analysis in Health Informatics and Bioinformatics"},{"key":"1677_CR34","doi-asserted-by":"crossref","unstructured":"Alkhateeb A, Atikukke G, Porter L, Fifield B-A, Cavallo-Medved D, Facca J, El-Gohary Y, Zhang T, Hamzeh O, Rueda L, et al. Comprehensive targeted gene profiling to determine the genomic signature likely to drive progression of high-grade nonmuscle invasive bladder cancer to muscle invasive bladder cancer. J Clin Oncol. 2020;38(6_suppl):568.","DOI":"10.1200\/JCO.2020.38.6_suppl.568"},{"issue":"1","key":"1677_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12916-024-03700-9","volume":"22","author":"D Gill","year":"2024","unstructured":"Gill D, Dib M-J, Cronj\u00e9 HT, Karhunen V, Woolf B, Gagnon E, Daghlas I, Nyberg M, Drakeman D, Burgess S. Common pitfalls in drug target Mendelian randomization and how to avoid them. BMC Med. 2024;22(1):473.","journal-title":"BMC Med"},{"issue":"8","key":"1677_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamaoncol.2016.1854","volume":"2","author":"DE Spratt","year":"2016","unstructured":"Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi OO, Osborne JR. Racial\/ethnic disparities in genomic sequencing. JAMA Oncol. 2016;2(8):1070\u20134.","journal-title":"JAMA Oncol"},{"issue":"12","key":"1677_CR37","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1093\/hmg\/dds098","volume":"21","author":"Wallace C, Rotival M, Cooper JD, Rice CM, Yang JH, McNeill M, Smyth DJ, Niblett D, Cambien F, Consortium C","year":"2012","unstructured":"Wallace C, Rotival M, Cooper JD, Rice CM, Yang JH, McNeill M, Smyth DJ, Niblett D, Cambien F, Consortium C. Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes. Hum Mol Genet. 2012;21(12):2815\u201324.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1677_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/ije\/dyh132","volume":"33","author":"GD Smith","year":"2004","unstructured":"Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30\u201342.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01677-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T02:02:08Z","timestamp":1734746528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01677-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01677-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving humans did not necessitate ethical approval in accordance with local legislation and institutional requirements. Participants or their legal guardians\/next of kin were not required to provide written informed consent to participate in this study, in line with national legislation and institutional requirements. The study protocol and details were not pre-registered.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}